VivoSeq
Other

Labor Induction at Term

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Labor Induction at Term is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Completed3 · 75%
Suspended1 · 25%

Clinical Trials

Trial Activity

Foley Catheter Versus PGE2 for Labor Induction at Term: a Pilot Study
Suspended·GGuangzhou Women and Children's Medical Center·Phase 4·NCT04780269·200 enrolled
Sublingual Versus Vaginal Misoprostol for Labor Induction at Term
Completed·—·Phase 3·NCT00140114·170 enrolled
Efficacy and Safety of Titrated Oral Misoprostol Solution for Labor Induction at Term
Completed·UUniversity of Manitoba·N/A·NCT01070472·250 enrolled
Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term
Completed·—·Phase 3·NCT00529295·220 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)